# Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

Study · id `cardio:ct-nct04505618` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04505618](<https://clinicaltrials.gov/study/NCT04505618>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04505618

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1050 participants.

## Technical summary

Registry record NCT04505618. Non-randomized; single masking; primary purpose screening. Start 2019-10-01 (actual); primary completion 2027-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; single masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 1050 participants (planned count; ClinicalTrials.gov record NCT04505618, source copy `cardio:ctgov-nct04505618-2026-06-17`, retrieved 2026-10-26)
- Started: 2019-10-01 (actual) (ClinicalTrials.gov record NCT04505618, source copy `cardio:ctgov-nct04505618-2026-06-17`, retrieved 2026-10-26)
- Primary completion: 2027-06-01 (anticipated) (ClinicalTrials.gov record NCT04505618, source copy `cardio:ctgov-nct04505618-2026-06-17`, retrieved 2026-10-26)
- Completion: 2027-09-01 (anticipated) (ClinicalTrials.gov record NCT04505618, source copy `cardio:ctgov-nct04505618-2026-06-17`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04505618, source copy `cardio:ctgov-nct04505618-2026-06-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04505618-2026-06-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- Acronym: OCTA-RVD
- Condition: Diabetic Retinopathy
- Condition: Retinal Vein Occlusion
- Condition: Hypertension,Essential
- Condition: Retinal Vascular Disorder
- Intervention (Device): Swept-Source (SS) OCT Angiography
- Intervention (Device): Spectral-Domain (SD) OCT Angiography
- Intervention (Device): Fundus Imaging
- Intervention (Device): Axial Length Measurement Device
- Lead sponsor: Johns Hopkins University
- Lead sponsor class: OTHER
- Collaborator: National Eye Institute (NEI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Johns Hopkins University (`cardio:org-johns-hopkins-university`)

## Provenance

Content hash: 86c98881267e2684bb36710ddaea38a30137dd2ef137484db2c4a3c2c42074c7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
